Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The global refurbished medical device market is expected to hit $8.45 billion by 2017, growing at a compound annual growth rate of 7.8 percent, according to a Markets and Markets report.
The U.S. Food and Drug Administration has given St. Paul, Minn.-based Smiths Medical 510(k) clearance to market its CADD-Solis Pain Management system with programmed intermittent bolus and patient controlled analgesics delivery, according to a news release.
The U.S. Food and Drug Administration has expanded approval for Flagstaff, Ariz.-based Gore Medical's Viabahn Endoprosthesis to be used for narrow or blocked blood vessels and blood clots where a vein and anrteriovenous access graft connect, according to a news…
Researchers at Carnegie Mellon University in Pittsburgh are developing a biodegradable, edible battery powered by the ink of a cuttlefish, according to an MIT Technology Review report.
Deerfield, Ill.-based Baxter International has issued a voluntary recall of certain lots of its 5% Dextrose Injection and 0.9% Sodium Chloride Injection due to particulate matter in the solution.
Medina, Ohio-based Scott Sheldon consulting firm released the second of its three-part whitepaper discussing the future of healthcare. Part two focuses on how healthcare providers, distributors and manufacturers can transition their goals and focus to adapt to the changing healthcare…
Lake Forest, Ill.-based Hospira has voluntarily recalled one lot of Lidocaine HCl Injection, USP, 2%, a local anesthetic, due to particles floating in the solution.
Here are the four latest medical device recalls compiled on Becker’s Hospital Review, starting with the most recent.
Adopting an advanced inventory management system reduced the costs of medical and surgical tools used in the operating room, according to a study released by the Center for Innovation and Healthcare Logistics at the University of Arkansas in Fayetteville.
The global drug device combination products market is expected to reach $115.1 billion by 2019, growing at a compound annual growth rate of 7.9 percent, according to a news release.